Addressing Neurologic Toxicities in CAR-T Therapy: Monitoring, Management, and Patient Communication

News
Video

The discussion focuses on monitoring and managing neurologic toxicities like ICANS in CAR-T therapy, highlighting tools for early detection, effective management strategies, and approaches to communicating risks with patients and caregivers.

Video content above is prompted by the following:

  • Neurologic toxicities, such as ICANS, pose unique challenges. How do you approach monitoring and management of these events in your practice?
  • What tools or assessment methods help you identify early signs of neurotoxicity?
  • How do you communicate these risks to patients and their caregivers?

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Image of a woman with gray hair on a light blue background
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a private infusion bay with a large screen for video calls
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a man wearing scrubs in front of a blue background
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with blonde hair wearing a denim jacket in front of a blue background
Related Content